Active Biotech AB (publ) filed its Annual on Apr 26, 2023 for the period ending Dec 31, 2022. In this report its auditor, KPMG LLP - Klynveld Peat Marwick Goerdeler, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.567 SEK | +6.38% | +2.53% | +24.21% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+24.21% | 18.71M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ACTI Stock
- News Active Biotech AB
- Active Biotech AB Auditor Raises 'Going Concern' Doubt